Clinical trial

Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors

NCT00008086 · University of Pittsburgh, Other · Completed

Key facts

NCT number NCT00008086
Title Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors
Official title A Phase I Trial of Subcutaneous And/Or Oral Calcitriol [(1,25-COH)2D3] and Carboplatin in Advanced Solid Tumors
Lead sponsor University of Pittsburgh, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 1
Study type Interventional
Conditions Brain and Central Nervous System Tumors, Unspecified Adult Solid Tumor, Protocol Specific
Intervention type Dietary Supplement, Drug
Interventions calcitriol, carboplatin
Start date Jan 1, 1996
Primary completion Sep 1, 2004
Completion Sep 1, 2004
First posted Sep 4, 2003
Last update posted Dec 19, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies